Baylon, Homer D.
HRN: 02-43-82 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/16/2024
CEFTRIAXONE 1G (VIAL)
09/16/2024
09/22/2024
IV
2g
OD
Post Op Removal Of Lipoma
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes